Palliative Percutaneous Biliary Interventions in Malignant High Bile Duct Obstruction

Amy R. Deipolyi; Anne M. Covey

doi:10.1055/s-0037-1608827

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2017; 34(04): 361-368
DOI: 10.1055/s-0037-1608827

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Palliative Percutaneous Biliary Interventions in Malignant High Bile Duct Obstruction

Authors

Amy R. Deipolyi

¹Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, New York, New York
Anne M. Covey

¹Department of Radiology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical Center, New York, New York

Abstract

The optimal palliative intervention for malignant biliary obstruction is internal drainage by placement of a metallic stent. For patients with hilar biliary obstruction or low bile duct obstruction in whom endoscopy is not feasible, a percutaneous transhepatic approach in interventional radiology is preferred. This article reviews the rationale for this approach, periprocedural management, and techniques to optimize stent patency.

Keywords

interventional radiology - biliary obstruction - bile duct obstruction - stent - biliary drainage

Full Text

References

References
1 Shepherd HA, Royle G, Ross AP, Diba A, Arthur M, Colin-Jones D. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988; 75 (12) 1166-1168
2 Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994; 344 (8938): 1655-1660
3 Covey AM, Brown KT. Palliative percutaneous drainage in malignant biliary obstruction. Part 2: Mechanisms and postprocedure management. J Support Oncol 2006; 4 (07) 329-335
4 Wright BE, Cass OW, Freeman ML. ERCP in patients with long-limb Roux-en-Y gastrojejunostomy and intact papilla. Gastrointest Endosc 2002; 56 (02) 225-232
5 Covey AM, Brown KT. Palliative percutaneous drainage in malignant biliary obstruction. Part 1: indications and preprocedure evaluation. J Support Oncol 2006; 4 (06) 269-273
6 Abraham NS, Barkun JS, Barkun AN. Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 2002; 56 (06) 835-841
7 Robson PC, Heffernan N, Gonen M. , et al. Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Ann Surg Oncol 2010; 17 (09) 2303-2311
8 Saluja SS, Gulati M, Garg PK. , et al. Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol 2008; 6 (08) 944-950.e3
9 Ring EJ, Kerlan Jr RK. Interventional biliary radiology. AJR Am J Roentgenol 1984; 142 (01) 31-34
10 Patel IJ, Davidson JC, Nikolic B. , et al; Standards of Practice Committee, with Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Endorsement. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 2012; 23 (06) 727-736
11 Westphal JF, Brogard JM, Caro-Sampara F. , et al. Assessment of biliary excretion of piperacillin-tazobactam in humans. Antimicrob Agents Chemother 1997; 41 (08) 1636-1640
12 Venkatesan AM, Kundu S, Sacks D. , et al; Society of Interventional Radiology Standards of Practice Committee. Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. [corrected] J Vasc Interv Radiol 2010; 21 (11) 1611-1630 , quiz 1631
13 Mueller PR, Ferrucci Jr JT, vanSonnenberg E. , et al. Obstruction of the left hepatic duct: diagnosis and treatment by selective fine-needle cholangiography and percutaneous biliary drainage. Radiology 1982; 145 (02) 297-302
14 Winick AB, Waybill PN, Venbrux AC. Complications of percutaneous transhepatic biliary interventions. Tech Vasc Interv Radiol 2001; 4 (03) 200-206
15 McNicholas MM, Lee MJ, Dawson SL. , et al. Complications of percutaneous biliary drainage and stricture dilatation. Semin Intervent Radiol 1994; 11: 242-253
16 Thornton RH, Ulrich R, Hsu M. , et al. Outcomes of patients undergoing percutaneous biliary drainage to reduce bilirubin for administration of chemotherapy. J Vasc Interv Radiol 2012; 23 (01) 89-95
17 Eklund JW, Trifilio S, Mulcahy MF. Chemotherapy dosing in the setting of liver dysfunction. Oncology (Williston Park) 2005; 19 (08) 1057-1063 , discussion 1063–1064, 1069
18 Piñol V, Castells A, Bordas JM. , et al. Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 2002; 225 (01) 27-34
19 Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB 2015; 17 (08) 691-699
20 Beddy P, Ryan JM. Antibiotic prophylaxis in interventional radiology--anything new?. Tech Vasc Interv Radiol 2006; 9 (02) 69-76
21 Okamoto T, Fujioka S, Yanagisawa S. , et al. Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis. Gastrointest Endosc 2006; 63 (06) 792-796
22 Brody LA, Brown KT, Getrajdman GI. , et al. Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage. J Vasc Interv Radiol 1998; 9 (04) 572-578
23 Kloek JJ, van der Gaag NA, Aziz Y. , et al. Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. J Gastrointest Surg 2010; 14 (01) 119-125
24 Paik WH, Park YS, Hwang JH. , et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 2009; 69 (01) 55-62
25 Walter T, Ho CS, Horgan AM. , et al. Endoscopic or percutaneous biliary drainage for Klatskin tumors?. J Vasc Interv Radiol 2013; 24 (01) 113-121
26 Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998; 47 (05) 354-362
27 Rerknimitr R, Kladcharoen N, Mahachai V, Kullavanijaya P. Result of endoscopic biliary drainage in hilar cholangiocarcinoma. J Clin Gastroenterol 2004; 38 (06) 518-523
28 Jo JH, Park BH. Suprapapillary versus transpapillary stent placement for malignant biliary obstruction: which is better?. J Vasc Interv Radiol 2015; 26 (04) 573-582
29 Thornton RH, Frank BS, Covey AM. , et al. Catheter-free survival after primary percutaneous stenting of malignant bile duct obstruction. AJR Am J Roentgenol 2011; 197 (03) W514-8
30 Hann LE, Getrajdman GI, Brown KT. , et al. Hepatic lobar atrophy: association with ipsilateral portal vein obstruction. AJR Am J Roentgenol 1996; 167 (04) 1017-1021
31 Takayasu K, Muramatsu Y, Shima Y, Moriyama N, Yamada T, Makuuchi M. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 1986; 160 (02) 389-393
32 Sofue K, Arai Y, Takeuchi Y, Fujiwara H, Tokue H, Sugimura K. Safety and efficacy of primary metallic biliary stent placement with tract embolization in patients with massive ascites: a retrospective analysis of 16 patients. J Vasc Interv Radiol 2012; 23 (04) 521-527
33 Maybody M, Brown KT, Brody LA. , et al. Primary patency of Wallstents in malignant bile duct obstruction: single vs. two or more noncoaxial stents. Cardiovasc Intervent Radiol 2009; 32 (04) 707-713
34 Brountzos EN, Ptochis N, Panagiotou I, Malagari K, Tzavara C, Kelekis D. A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting. Cardiovasc Intervent Radiol 2007; 30 (01) 66-73
35 De Palma GD, Galloro G, Siciliano S, Iovino P, Catanzano C. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc 2001; 53 (06) 547-553
36 Hamada T, Isayama H, Nakai Y. , et al. Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer. Gastrointest Endosc 2011; 74 (03) 548-555
37 Matsuda Y, Shimakura K, Akamatsu T. Factors affecting the patency of stents in malignant biliary obstructive disease: univariate and multivariate analysis. Am J Gastroenterol 1991; 86 (07) 843-849
38 van Boeckel PG, Steyerberg EW, Vleggaar FP. , et al. Multicenter study evaluating factors for stent patency in patients with malignant biliary strictures: development of a simple score model. J Gastroenterol 2011; 46 (09) 1104-1110
39 Loew BJ, Howell DA, Sanders MK. , et al. Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc 2009; 70 (03) 445-453
40 Dumonceau JM, Devière J. Self-expandable metal stents. Best Pract Res Clin Gastroenterol 1999; 13 (01) 109-130
41 Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992; 340 (8834-8835): 1488-1492
42 Saleem A, Leggett CL, Murad MH, Baron TH. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc 2011; 74 (02) 321-327.e1 , 3
43 Willingham FF. All wrapped up: metal biliary stents and the effect of stent coverings. Gastrointest Endosc 2010; 72 (05) 924-926
44 Lorenz JM. Management of malignant biliary obstruction. Semin Intervent Radiol 2016; 33 (04) 259-267
45 Isayama H, Komatsu Y, Tsujino T. , et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut 2004; 53 (05) 729-734
46 Kullman E, Frozanpor F, Söderlund C. , et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc 2010; 72 (05) 915-923
47 Hyun H, Choi SY, Kim KA, Ko SB. Safety and efficacy of percutaneous biliary covered stent placement in patients with malignant biliary hilar obstruction; correlation with liver function. Cardiovasc Intervent Radiol 2016; 39 (09) 1298-1305
48 Suk KT, Kim JW, Kim HS. , et al. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study. Gastrointest Endosc 2007; 66 (04) 798-803
49 Jang SI, Kim JH, You JW. , et al. Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study. Dig Dis Sci 2013; 58 (03) 865-871
50 Song TJ, Lee SS, Yun SC. , et al. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study. Gastrointest Endosc 2011; 73 (04) 727-733
51 Mizandari M, Pai M, Xi F. , et al. Percutaneous intraductal radiofrequency ablation is a safe treatment for malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol 2013; 36 (03) 814-819
52 Pai M, Valek V, Tomas A. , et al. Percutaneous intraductal radiofrequency ablation for clearance of occluded metal stent in malignant biliary obstruction: feasibility and early results. Cardiovasc Intervent Radiol 2014; 37 (01) 235-240
53 Aggarwal R, Patel FD, Kapoor R, Kang M, Kumar P, Chander Sharma S. Evaluation of high-dose-rate intraluminal brachytherapy by percutaneous transhepatic biliary drainage in the palliative management of malignant biliary obstruction--a pilot study. Brachytherapy 2013; 12 (02) 162-170
54 Chen Y, Wang X-L, Yan Z-P. , et al. The use of ¹²⁵I seed strands for intraluminal brachytherapy of malignant obstructive jaundice. Cancer Biother Radiopharm 2012; 27 (05) 317-323
55 Zhu HD, Guo JH, Zhu GY. , et al. A novel biliary stent loaded with (125)I seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent. J Hepatol 2012; 56 (05) 1104-1111